Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,17 € ↓ -0,02 (-0,39%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionState Street Corp
Latest Disclosed Ownership3,015,562 shares
Ownership 5.10%
State Street Corp ownership in VM4 / Vanda Pharmaceuticals Inc.

2026-05-12 - State Street Corp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,015,562 shares of Vanda Pharmaceuticals Inc. (DE:VM4). This represents 5.1 percent ownership of the company. In their previous filing dated 2024-01-22 , State Street Corp had reported owning 1,228,096 shares, indicating an increase of 145.55 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-05-12 2026-05-12 13G 1,228,096 3,015,562 145.55 5.10 139.44
2024-01-22 2024-01-22 13G/A 3,727,798 1,228,096 -67.06 2.13 -67.68
2023-02-07 2023-02-07 13G/A 3,327,433 3,727,798 12.03 6.59 10.39
2022-02-14 2022-02-14 13G/A 3,203,904 3,327,433 3.86 5.97 1.88
2021-02-11 2021-02-11 13G 3,203,904 5.86

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 3,015,562 1,752,023 138.66 20,838 86.98 0.0007
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,263,539 -7,540 -0.59 11,144 75.72 0.0004
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,271,079 5,232 0.41 6,343 6.16 0.0002
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,265,847 13,288 1.06 5,975 3.91 0.0002
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,252,559 68,696 5.80 5,749 1.39 0.0002
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,183,863 18,681 1.60 5,671 3.77 0.0002
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,165,182 -46,127 -3.81 5,465 -20.15 0.0002
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,211,309 8,014 0.67 6,844 38.38 0.0003
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,203,295 -24,801 -2.02 4,946 -4.57 0.0002
2024-02-14 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,228,096 -75,685 -5.81 5,183 -7.99 0.0003
2023-11-14 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,303,781 -2,776,855 -68.05 5,632 -79.06 0.0003
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 4,080,636 -471,276 -10.35 26,891 -12.99 0.0014
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 4,551,912 824,114 22.11 30,907 12.19 0.0017
2023-05-15 2022-12-31 13F/A-99 VANDA PHARMACEUTICALS COM 921659108 3,727,798 42,447 1.15 27,548 -24.34 0.0016
2023-05-15 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 3,727,798 42,447 27,548 0.0016
2022-11-15 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 3,685,351 -30,574 -0.82 36,411 -10.11 0.0023
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 3,715,925 -347,373 -8.55 40,504 -11.86 0.0024
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 4,063,298 735,865 22.12 45,956 -11.97 0.0023
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 3,327,433 -70,609 -2.08 52,207 -10.36 0.0025
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 3,398,042 236,533 7.48 58,242 -14.36 0.0031
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 3,161,509 -150,830 -4.55 68,004 36.69 0.0036
2021-07-09 2021-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 3,312,339 108,435 3.38 49,751 18.18 0.0029
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 3,312,339 108,435 49,751 0.0029
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 3,203,904 -181,430 -5.36 42,099 28.74 0.0026
2020-11-10 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 3,385,334 -293,278 -7.97 32,702 -22.29 0.0022
2020-08-14 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 3,678,612 842,696 29.72 42,083 43.24 0.0031
2020-06-19 2020-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 2,835,916 301,896 11.91 29,380 -29.35 0.0026
2020-05-11 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 2,835,916 301,896 29,380 2,580.1556
2020-02-06 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 2,534,020 -331,817 -11.58 41,583 9.26 0.0028
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 2,865,837 -134,979 -4.50 38,058 -9.99 0.0028
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 3,000,816 -671,993 -18.30 42,281 -37.44 0.0032
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 3,672,809 1,200,854 48.58 67,580 4.63 0.0053
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 2,471,955 -59,786 -2.36 64,592 11.17 0.0059
2018-11-09 2018-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,531,741 358,730 16.51 58,100 40.34 0.0045
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,173,011 288,921 15.33 41,399 30.40 0.0035
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,884,090 -251,137 -11.76 31,747 -2.18 0.0027
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,135,227 486,595 29.52 32,456 9.99 0.0026
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,648,632 30,147 1.86 29,507 11.85 0.0025
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,618,485 46,299 2.94 26,380 19.87 0.0023
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,572,186 -179,419 -10.24 22,007 -21.22 0.0020
2017-02-09 2016-12-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,751,605 374,095 27.16 27,935 21.88 0.0026
2017-01-13 2016-09-30 13F/A-1 VANDA PHARMACEUTICALS Common equity shares 921659108 1,377,510 92,456 7.19 22,921 59.34 0.0023
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,377,510 22,921
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,285,054 -203,313 -13.66 14,385 15.62 0.0015
2016-05-20 2016-03-31 13F/A-1 VANDA PHARMACEUTICALS Common equity shares 921659108 1,488,367 -200,399 -11.87 12,442 -20.86 0.0013
2016-05-12 2016-03-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,488,367 12,442
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,688,766 -799,413 -32.13 15,721 -43.99 0.0017
2015-11-16 2015-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,488,179 -81,438 -3.17 28,066 -13.93 0.0033
2015-08-13 2015-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,569,617 -115,978 -4.32 32,610 30.58 0.0035
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 2,685,595 808,011 43.03 24,974 -7.12 0.0026
2015-02-11 2014-12-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,877,584 65,250 3.60 26,888 42.94 0.0027
2014-11-12 2014-09-30 13F/A-1 VANDA PHARMACEUTICALS Common equity shares 921659108 1,812,334 260,416 16.78 18,811 -25.09 0.0020
2014-11-10 2014-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,812,334 18,811
2014-08-12 2014-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,551,918 -2,512 -0.16 25,110 -0.60 0.0027
2014-05-15 2014-03-31 13F/A-1 VANDA PHARMACEUTICALS Common equity shares 921659108 1,554,430 988,158 174.50 25,262 259.60 0.0029
2014-05-13 2014-03-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 1,554,630 25,265
2014-02-06 2013-12-31 13F/A-1 VANDA PHARMACEUTICALS Common equity shares 921659108 566,272 41,440 7.90 7,025 21.92 0.0008
2014-02-06 2013-12-31 13F VANDA PHARMACEUTICALS Common equity shares 921659108 532,356 1,969
2013-11-12 2013-09-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 524,832 14,314 2.80 5,762 39.68 0.0007
2013-08-08 2013-06-30 13F VANDA PHARMACEUTICALS Common equity shares 921659108 510,518 510,518 4,125 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.